Ellevest, Inc. Neoleukin Therapeutics, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$0.92 - $2.25 $56 - $137	61 New	61 $0
Q1 2022 Apr 19, 2022	SELL	$1.72 - $5.23 $51 - $156	-30 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$4.65 - $7.75 $27 - $46	6 Added 25.0%	30 $0
Q3 2021 Oct 19, 2021	BUY	$6.05 - $9.66 $145 - $231	24 New	24 $0
Q4 2020 Feb 04, 2021	SELL	$10.17 - $14.56 $1,413 - $2,023	-139 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$9.68 - $17.01 $1,345 - $2,364	139 New	139 $2,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.